Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3146428 | 0.88 | F10 (0.45) | F10 | |
| SCHEMBL3156588 | 0.81 | F10 (0.44) | F10 | |
| SCHEMBL4557761 | 0.81 | F10 (0.62) | F10F2 | |
| SCHEMBL3148052 | 0.81 | F10 (0.40) | F10 | |
| SCHEMBL3146160 | 0.80 | F10 (0.47) | F10 | |
| SCHEMBL3151799 | 0.80 | F10 (0.50) | F10 | |
| SCHEMBL3151508 | 0.78 | F10 (0.69) | F10F2 | |
| SCHEMBL3160134 | 0.78 | F10 (0.36) | F10 | |
| SCHEMBL3156175 | 0.78 | F10 (0.44) | F10F2 | |
| SCHEMBL3375924 | 0.78 | F10 (0.44) | F10F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2099453-A2 | COMBINATION THERAPY OF SUBSTITUTED OXAZOLIDINONES | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-09-16 | — | — | EP | disclosed |
| WO-2008052671-A2 | COMBINATION THERAPY OF SUBSTITUTED OXAZOLIDINONES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-05-08 | — | — | WO | disclosed |